Fact CheckerSign in

NCT06447272Not yet recruiting

Effects of IMT on Respiratory, Diaphragmatic and Balance Functions, Exercise Capacity and QOL in People After Stroke

Effects of Inspiratory Muscle Training on Respiratory and Diaphragmatic Functions, Balance Control, Exercise Capacity and Quality of Life in People After Stroke: a Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 13 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is a randomized controlled trial. This current RCT study will be a continuing project based on the optimal IMT intensity identified from our ongoing study. This ongoing study (registered on ClinicalTrials.gov with the registration number NCT06267768) aims to explore the optimal IMT intensity for the recruitment of diaphragm muscles in people after a stroke. Based on this intensity, the aim of this RCT is to explore the effects of a 4-week protocol of IMT on respiratory function, balance control, exercise capacity, and quality of life in people after a stroke.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
76 (estimated)
First submitted
28 May 2024
Start date
1 Apr 2025
Primary completion date
1 May 2026
Lead sponsor
Hong Kong Metropolitan University
Diseases
Stroke
NCT number
NCT06447272

What you commit to

  • Study type: Interventional
  • Planned participants: 76
  • From 1 Apr 2025 to the primary completion date, 1 May 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • acute myocardial infarction or acute heart failure;
  • with respiratory illness or positive clinical signs of impaired respiratory function, such as shortness of breath, hypoxemia, chronic cough, or sputum retention;
  • Trunk Impairment Scale (TIS) score ≥ 20;
  • presence of a nasal feeding tube, tracheal tube, or any condition that prevents the measurement or implementation of the study procedure.

Other

  • acute pain in any part of the body;
  • with chronic cardiovascular dysfunction;

Who the study is looking for

  • aged between 40 and 80 years;
  • breathing spontaneously;
  • clinically diagnosed with ischemic and/or haemorrhagic stroke;
  • stroke duration from onset between 1 and 12 months;
  • no history of thoracic or abdominal surgery within the last 6 months;
  • able to understand and follow verbal instructions;
  • no facial palsy, or mild facial palsy without limitation of labial occlusion;
  • capable of maintaining a resting sitting posture without feet support for at least 30 seconds;
  • no cognitive impairment, as indicated by a Montreal Cognitive Assessment (MoCA) score of ≥ 26;
  • able to independently walk at least 10 meters with or without an assistive device.

Age in the registry: 40 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.